Trillium Asset Management LLC has called for the separation of Johnson & Johnson’s (JNJ.N) chairman and chief executive officer roles, currently held by Alex Gorsky, according to a regulatory filing here by the healthcare conglomerate on Monday.
The asset management firm is seeking a vote on the shareholder proposal at J&J’s annual meeting on April 23.
https://www.reuters.com/article/us-johnson-johnson-trillium-asset/trillium-asset-calls-for-separation-of-jjs-ceo-and-chairman-roles-idUSKBN20P39O
Monday, March 2, 2020
Ex-CDC head Tom Frieden says kids may be secret coronavirus carriers
The ex-director of the US Centers for Disease Control and Prevention said Monday that the deadly coronavirus may be “impossible” to contain — and that kids may be secret carriers of the disease.
“We think it will be very difficult if not impossible to contain it … but that doesn’t mean we shouldn’t try,” Dr. Tom Frieden told reporters.
Frieden, who ran the agency under President Obama and was the New York City health commissioner under Mayor Mike Bloomberg, said the spread of the virus to more than 89,000 people across the world has been an “unprecedented situation.”
“Never before have we seen a pathogen emerge and have global spread like this. That is scary,” Frieden said.
Frieden pointed to evidence that people with mild or no symptoms, including children, may be secret carriers of the virus.
He cited a report of a 10-year-old boy who visited the outbreak’s epicenter in China and didn’t show any symptoms of the virus. But when the boy’s parents insisted doctors test him, he was diagnosed with the virus, according to the Lancet medical journal.
“The fact that children may get infected but not show symptoms poses a risk to pediatricians,” Frieden said.
The virus, known as COVID-19, has been most deadly with patients who are older or have underlying health problems, he said.
The disease, which has now reached 65 countries, has caused more than 3,000 deaths since December’s outbreak in Wuhan, China.
Symptoms include a fever, cough and shortness of breath.
https://nypost.com/2020/03/02/ex-cdc-head-tom-frieden-says-kids-may-be-secret-coronavirus-carriers/
“We think it will be very difficult if not impossible to contain it … but that doesn’t mean we shouldn’t try,” Dr. Tom Frieden told reporters.
Frieden, who ran the agency under President Obama and was the New York City health commissioner under Mayor Mike Bloomberg, said the spread of the virus to more than 89,000 people across the world has been an “unprecedented situation.”
“Never before have we seen a pathogen emerge and have global spread like this. That is scary,” Frieden said.
Frieden pointed to evidence that people with mild or no symptoms, including children, may be secret carriers of the virus.
He cited a report of a 10-year-old boy who visited the outbreak’s epicenter in China and didn’t show any symptoms of the virus. But when the boy’s parents insisted doctors test him, he was diagnosed with the virus, according to the Lancet medical journal.
“The fact that children may get infected but not show symptoms poses a risk to pediatricians,” Frieden said.
The virus, known as COVID-19, has been most deadly with patients who are older or have underlying health problems, he said.
The disease, which has now reached 65 countries, has caused more than 3,000 deaths since December’s outbreak in Wuhan, China.
Symptoms include a fever, cough and shortness of breath.
https://nypost.com/2020/03/02/ex-cdc-head-tom-frieden-says-kids-may-be-secret-coronavirus-carriers/
Vertex Pharmaceuticals Cancels March 3 Presentation at Cowen
Vertex Pharmaceuticals Inc. said Monday it was canceling a planned
March 3 presentation and webcast at the Cowen Health Care Conference.
“Following implementation of a companywide travel and meetings policy that is designed to reduce potential disruption from coronavirus, the Vertex senior management team will, as a precautionary measure, no longer attend the conference,” the biotechnology company said.
https://www.marketscreener.com/VERTEX-PHARMACEUTICALS-11321/news/Vertex-Pharmaceuticals-Cancels-March-3-Presentation-at-Cowen-Health-Care-Conference-30095834/
“Following implementation of a companywide travel and meetings policy that is designed to reduce potential disruption from coronavirus, the Vertex senior management team will, as a precautionary measure, no longer attend the conference,” the biotechnology company said.
https://www.marketscreener.com/VERTEX-PHARMACEUTICALS-11321/news/Vertex-Pharmaceuticals-Cancels-March-3-Presentation-at-Cowen-Health-Care-Conference-30095834/
PTC Therapeutics down 5% after hours as product sales growth remains modest
PTC Therapeutics (NASDAQ:PTCT) Q4 results:
Revenues: $96.5M (+11.8%); Translarna sales: $48.4M (-13.6%); Emflaza sales: $32.7M (+9.7%).
Net loss: ($77.7M); loss/share: ($1.37).
2020 guidance: DMD franchise revenue: $320M – 340M.
Shares down 5% after hours.
https://seekingalpha.com/news/3547733-ptc-therapeutics-down-5-after-hours-product-sales-growth-remains-modestOmeros EPS beats by $0.01, beats on revenue
Revenue of $33.42M (+51.8% Y/Y) beats by $1.67M.
Shares +2.5%.
https://seekingalpha.com/news/3547655-omeros-eps-beats-0_01-beats-on-revenueuniQure EPS misses by $0.29, beats on revenue
uniQure (NASDAQ:QURE): FY GAAP EPS of -$3.11 misses by $0.29.
Revenue of $7.28M (-35.5% Y/Y) beats by $1.19M.
https://seekingalpha.com/news/3547674-precigen-eps-misses-0_19-misses-on-revenueBeiGene EPS misses by $1.39, misses on revenue
BeiGene (NASDAQ:BGNE): Q4 GAAP EPS of -$6.39 misses by $1.39.
Revenue of $56.89M (-3.0% Y/Y) misses by $3.36M.
https://seekingalpha.com/news/3547680-beigene-eps-misses-1_39-misses-on-revenue
Subscribe to:
Comments (Atom)